chr14-94614466-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001085.5(SERPINA3):c.25G>A(p.Ala9Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.469 in 1,613,324 control chromosomes in the GnomAD database, including 182,455 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001085.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SERPINA3 | NM_001085.5 | c.25G>A | p.Ala9Thr | missense_variant | 2/5 | ENST00000393078.5 | |
SERPINA3 | NM_001384672.1 | c.25G>A | p.Ala9Thr | missense_variant | 2/5 | ||
SERPINA3 | NM_001384673.1 | c.25G>A | p.Ala9Thr | missense_variant | 3/6 | ||
SERPINA3 | NM_001384674.1 | c.25G>A | p.Ala9Thr | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SERPINA3 | ENST00000393078.5 | c.25G>A | p.Ala9Thr | missense_variant | 2/5 | 1 | NM_001085.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.408 AC: 61947AN: 151742Hom.: 13825 Cov.: 31
GnomAD3 exomes AF: 0.446 AC: 111980AN: 251012Hom.: 26860 AF XY: 0.456 AC XY: 61827AN XY: 135668
GnomAD4 exome AF: 0.475 AC: 694720AN: 1461464Hom.: 168623 Cov.: 51 AF XY: 0.476 AC XY: 345936AN XY: 727040
GnomAD4 genome AF: 0.408 AC: 61968AN: 151860Hom.: 13832 Cov.: 31 AF XY: 0.413 AC XY: 30645AN XY: 74198
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
ANTICHYMOTRYPSIN SIGNAL PEPTIDE POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Mar 01, 1997 | - - |
SERPINA3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at